Balaxi Pharmaceuticals fundamental analysis
BALAXI
25.44
1.01 (-3.82%)Last updated on 9 Jan, 2026 | 15:49 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Balaxi Pharmaceuticals Fundamentals
P/E Ratio
9.69
P/B Ratio
0.59
Div. Yield
0
Sector P/E
39.44
Sector P/B
2.63
Sec. Div. Yield
85.01
Balaxi Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 9.69, compared to the sector average of 39.44. Its P/B Ratio stands at 0.59, while the sector’s is 2.63. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 85.01%.
Balaxi Pharmaceuticals Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Balaxi Pharmaceuticals reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
